Chemical Profiles and Pharmacological Properties with in Silico Studies on Elatostema papillosum Wedd

The current study attempted, for the first time, to qualitatively and quantitatively determine the phytochemical components of Elatostema papillosum methanol extract and their biological activities. The present study represents an effort to correlate our previously reported biological activities with a computational study, including molecular docking, and ADME/T (absorption, distribution, metabolism, and excretion/toxicity) analyses, to identify the phytochemicals that are potentially responsible for the antioxidant, antidepressant, anxiolytic, analgesic, and anti-inflammatory activities of this plant. In the gas chromatography-mass spectroscopy analysis, a total of 24 compounds were identified, seven of which were documented as being bioactive based on their binding affinities. These seven were subjected to molecular docking studies that were correlated with the pharmacological outcomes. Additionally, the ADME/T properties of these compounds were evaluated to determine their drug-like properties and toxicity levels. The seven selected, isolated compounds displayed favorable binding affinities to potassium channels, human serotonin receptor, cyclooxygenase-1 (COX-1), COX-2, nuclear factor (NF)-κB, and human peroxiredoxin 5 receptor proteins. Phytol acetate, and terpene compounds identified in E. papillosum displayed strong predictive binding affinities towards the human serotonin receptor. Furthermore, 3-trifluoroacetoxypentadecane showed a significant binding affinity for the KcsA potassium channel. Eicosanal showed the highest predicted binding affinity towards the human peroxiredoxin 5 receptor. All of these findings support the observed in vivo antidepressant and anxiolytic effects and the in vitro antioxidant effects observed for this extract. The identified compounds from E. papillosum showed the lowest binding affinities towards COX-1, COX-2, and NF-κB receptors, which indicated the inconsequential impacts of this extract against the activities of these three proteins. Overall, E. papillosum appears to be bioactive and could represent a potential source for the development of alternative medicines; however, further analytical experiments remain necessary.     

保健酒中淫羊霍苷成分的分析研究

采用高效液相色谱法对某保健酒中淫羊藿苷成分进行分析研究,结果表明,保健酒中淫羊藿苷的平均含量为0.627％,平均回收率为98.1％,相对标准差（RSD）为2.1％.本分析方法也适用于其他保健酒、药材和药品中淫羊藿苷成分的分析测定.     

氢化物发生ICP-AES法测定药用植物中的痕量锗

本文应用氢化物发生ＩＣＰ－ＡＥＳ法研究了药用植物样品中痕量锗的测定方法，系统地研究了ＩＣＰ－ＡＥＳ仪器参数及氢化物发生条件对锗谱线信背比的影响，考察了１３种共存元素的干扰，并比较了植物样品的３种前处理方法。选定Ｈ３ＰＯ４－ＨＮＯ３－Ｈ２Ｏ２消化，在３ｍｏｌ／ＬＨ３ＰＯ４介质中，以１５ｇ／ＬＮａＢＨ４还原，测定药用植物样品中的锗，相对标准偏差≤２．９％，回收率为９４％～１０３％。方法检出限达０．１３μｇ／Ｌ。     

英平诸痹灵药酒中钴,锶,锂含量分析

采用火焰原子吸收分光光度法测定５种英平诸痹灵药酒中钴、锶、锂的含量。结果表明，该类药酒中微量元素Ｓｒ含量较高，微量元素Ｃｏ、Ｌｉ含量较低，该结果为讨论抗类风湿药物中微量元素与治疗类风湿疾病的关系提供了有用数据。     

Modern Synthetic Methods for Fluorine‐Substituted Target Molecules

Fluorine has come to be recognized as a key element in materials science: in heat‐transfer agents, liquid crystals, dyes, surfactants, plastics, elastomers, membranes, and other materials. Furthermore, many fluorine‐containing biologically active agents are finding applications as pharmaceuticals and agrochemicals. Progress in synthetic fluorine chemistry has been critical to the development of these fields and has led to the invention of many novel fluorinated molecules as future drugs and materials. As a result of the electronic effects of fluorine substituents, fluorinated substrates and reagents often exhibit unusual and unique chemical properties, which often make them incompatible with established synthetic methods. Thus, the problem of how to control the unusual properties of compounds with fluorine substituents deserves much attention, so as to promote the design of facile, efficient, and environmentally benign methods for the synthesis of valuable organofluorine targets.     

藏药香芸火绒草Leontopodium Haplophylloides化学成分的研究

从藏药香芸火绒草Leontopodium Haplophylloides Hand Mazz的甲醇提取物中分得四个B环未取代的黄酮, 分别为乔松素(1), 高良姜素(2), 3, 7-二羟基-5-甲氧基黄(3), 3, 5-二羟基-7-甲氧基黄酮(4), 化合物(2)对人皮肤痤疮菌具有一定的疗效。     

New antimalarial drugs

Approximately 40% of the world population live in areas with the risk of malaria. Each year, 300-500 million people suffer from acute malaria, and 0.5-2.5 million die from the disease. Although malaria has been widely eradicated in many parts of the world, the global number of cases continues to rise. The most important reason for this alarming situation is the rapid spread of malaria parasites that are resistant to antimalarial drugs, especially chloroquine, which is by far the most frequently used. The development of new antimalarial drugs has been neglected since the 1970s owing to the end colonialism, changes in the areas of military engagement, and the restricted market potential. Only in recent years, in part supported by public funding programs, has interest in the development of antimalarial drugs been renewed. New data available from the recently sequenced genome of the malaria parasite Plasmodium falciparum and the application of methods of modern drug design promise to bring significant development in the fight against this disease.     

Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia

Parasitic diseases such as sleeping sickness, Chagas' heart disease, and malaria are major health problems in poverty-stricken areas. Antiparasitic drugs that are not only active but also affordable and readily available are urgently required. One approach to finding new drugs and rediscovering old ones is based on enzyme inhibitors that paralyze antioxidant systems in the pathogens. These antioxidant ensembles are essential to the parasites as they are attacked in the human host by strong oxidants such as peroxynitrite, hypochlorite, and H2O2. The pathogen-protecting system consists of some 20 thiol and dithiol proteins, which buffer the intraparasitic redox milieu at a potential of -250 mV. In trypanosomes and leishmania the network is centered around the unique dithiol trypanothione (N1,N8-bis(glutathionyl)spermidine). In contrast, malaria parasites have a more conservative dual antioxidative system based on glutathione and thioredoxin. Inhibitors of antioxidant enzymes such as trypanothione reductase are, indeed, parasiticidal but they can also delay or prevent resistance against a number of other antiparasitic drugs.